|
⚲
|
| Keyboard |
| Burkhardt Glen
✚
|
|
|---|---|
| CIK # | 0001803271 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001803271] | |
| 4 | [0001803271] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Burkhardt Glen | |
| PhaseBio Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2022-05-23 | Sell | 11,248 | $0.79 | 8,886 |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2022-05-20 | Grant | 11,248 | $0.68 | 7,649 |
|
PhaseBio Pharmaceuticals Inc PHAS
Employee Stock Option (right to buy) · derivative
|
2022-02-24 | Grant | 87,500 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Restricted Stock Unit · derivative
|
2022-02-24 | Grant | 18,750 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2021-11-19 | Grant | 5,766 | $2.01 | 11,590 |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2021-11-19 | Sell | 5,766 | $2.37 | 13,665 |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2021-05-20 | Sell | 3,811 | $3.29 | 12,538 |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2021-05-20 | Grant | 3,811 | $2.80 | 10,671 |
|
PhaseBio Pharmaceuticals Inc PHAS
Employee Stock Option (right to buy) · derivative
|
2021-02-05 | Grant | 36,000 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2020-11-23 | Sell | 3,497 | $3.45 | 12,065 |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2020-11-20 | Grant | 3,497 | $3.00 | 10,491 |
|
PhaseBio Pharmaceuticals Inc PHAS
Employee Stock Option (right to buy) · derivative
|
2020-02-12 | Grant | 55,000 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Employee Stock Option (right to buy) · derivative
|
2020-02-12 | Grant | 20,000 | $0.00 |